Skip to main content

Natus Sensory Appoints Arne Boye Nielsen to Board of Directors

Natus Sensory, a global leader in sensory and diagnostic solutions, today announced the appointment of Arne Boye Nielsen to its Board of Directors, effective January 1, 2026.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260107392331/en/

Arne Boye Nielsen

Arne Boye Nielsen

Arne brings more than 30 years of executive leadership experience in diagnostics and medical technology, most notably as President of Demant Diagnostics, where he built and scaled the business into a global leader over three decades. During his tenure, Arne played a central role in shaping Demant Diagnostics’ long-term strategy, portfolio expansion, and international growth, establishing it as a cornerstone of Demant’s global healthcare footprint.

In addition to his executive leadership background, Arne brings extensive board experience. His deep expertise across diagnostics, governance, and value creation will further strengthen Natus Sensory’s Board as the company continues to execute its growth and innovation strategy.

Strategic vision, deep industry expertise, and proven leadership

“We are delighted to welcome Arne to the Natus Sensory Board of Directors. His strategic vision, deep industry expertise, and proven leadership in driving global impact make him an ideal partner as we continue to scale our innovation and support customers worldwide. Arne’s insights will be invaluable as we build on our success and strive for continued excellence,” says Matthias Weber, Chairman of the Board of Directors, Natus Sensory.

“I am honoured to join the Board of Natus Sensory at such an exciting time in its growth journey. I look forward to working collaboratively with the Board and leadership team to support Natus Sensory’s mission and to contribute to its long-term strategic success,” says Arne Boye Nielsen.

About Natus Sensory

Natus Sensory is a global leader in solutions for assessing, fitting and screening in the areas of hearing, balance, vision and newborn care - making a meaningful difference in patient care. With a legacy of groundbreaking innovation, we are committed to improving outcomes for patients and supporting the daily work of healthcare professionals. At the core of our innovation is a dedication to listening to clinicians, ensuring every product addresses real-world challenges. Our solutions are known for their ease of use, reliability, and safety. Beyond products, Natus Sensory offers comprehensive training and education - empowering clinicians with the knowledge and support they need to deliver exceptional care.

Arne brings more than 30 years of executive leadership experience in diagnostics and medical technology, most notably as President of Demant Diagnostics, where he built and scaled the business into a global leader over three decades.

Contacts

For more information, please contact:

Catherine Conlon

Global Marketing & Communications

+45 22 36 40 52

Catherine.conlon@natus.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  246.29
+4.73 (1.96%)
AAPL  259.04
-1.29 (-0.50%)
AMD  204.68
-5.34 (-2.54%)
BAC  56.18
+0.54 (0.97%)
GOOG  326.01
+3.58 (1.11%)
META  646.06
-2.63 (-0.41%)
MSFT  478.11
-5.36 (-1.11%)
NVDA  185.04
-4.07 (-2.15%)
ORCL  189.65
-3.19 (-1.65%)
TSLA  435.80
+4.39 (1.02%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.